Study Details

Back
Study ID E05-CL-3002
Study Title A Randomized, Controlled, Long-term Safety Study Evaluating the Effect of Repeated Applications of QUTENZA™ plus Standard of Care versus Standard of Care alone in Patients with Painful Diabetic Peripheral Neuropathy (PACE)
Clinicaltrials.gov Identifier 01478607
Compound Name NGX-4010 (ASP0805) / capsaicin
Medical Indication or Disease Painful diabetic neuropathy
Study Sponsor Astellas Pharma Europe B.V. (APEB)
Collaborator Not Applicable
Study Start Date 10-Nov-2011
Study Completion Date 27-Feb-2014
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS